Continuing EmeraldLED green light therapy to reshape your body
Can EmeraldLED Reshape Your Body With Continued Use?
This remote study will see if continuing twice-weekly, 15-minute EmeraldLED green light sessions helps adults already using EmeraldLED improve body composition and mood.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Efforia, Inc Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT07282119 on ClinicalTrials.gov |
What this trial studies
This decentralized, remote trial enrolls current EmeraldLED users to continue a regimented course of twice-weekly, 15-minute green light sessions while providing body composition and mood data. Participants will submit measurements and questionnaires remotely, receive personalized feedback, and follow the protocol from home. The trial is organized by Efforia, Inc and led by the company's CEO, aiming to provide empirical data to address widespread anecdotal claims about green light benefits. Primary outcomes will track changes in body composition and self-reported well-being over the intervention period.
Who should consider this trial
Good fit: Ideal candidates are US residents who can read English, are already active EmeraldLED users, and are willing to follow remote protocol requirements.
Not a fit: People with eye conditions and individuals not currently using EmeraldLED are excluded and may not be eligible or receive benefit from this approach.
Why it matters
Potential benefit: If successful, continued EmeraldLED green light sessions could help users improve body composition and mood as a low-risk adjunct to lifestyle measures.
How similar studies have performed: Rigorous clinical evidence is limited and most support to date is anecdotal or from small, uncontrolled reports, so this approach remains largely untested in controlled trials.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with eye conditions * Individuals not active with EmeraldLED
Where this trial is running
New York, New York
- Efforia — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Matthew Amsden
- Email: help@efforia.com
- Phone: 646-679-2479
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.